George L. Sing - 03 Jan 2023 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Role: Director
Signature: /s/**George L. Sing
Issuer symbol: REGN
Transactions as of: 03 Jan 2023
Net transactions value: $0
Form type: 4
Filing time: 05 Jan 2023, 15:19:47 UTC
Previous filing: 01 Mar 2022
Next filing: 04 Jan 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	REGN	Common Stock	Award	$0	+165	+0.63%	$0.000000	26,214	03 Jan 2023	Direct	F1
holding	REGN	Common Stock						750	03 Jan 2023	by Spouse
holding	REGN	Common Stock						400	03 Jan 2023	by Spouse/Cust Son
holding	REGN	Common Stock						1,000	03 Jan 2023	by Trust for Son

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	REGN	Non-Qualified Stock Option (right to buy)	Award	$0	+1,929		$0.000000	1,929	03 Jan 2023	Common Stock	1,929	$725.89	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Reflects an acquisition of time-based vesting restricted stock units each representing a contingent right to receive one share of the Issuer's common stock.
F2	On the date of the Issuer's first annual meeting of shareholders following the date of grant, a portion of these stock options equal to the portion of one year that has passed from the date of grant shall then become exercisable, and the remainder shall become exercisable on the first anniversary of the date of grant.